|
Chembio Diagnostics, Inc. - Comparative Business Analysis Snapshot
Business Description
Chembio Diagnostics, Inc.. The Group's principal activity is to develop and manufacture rapid tests to aid in the detection of infectious diseases. The majority of revenues are generated through contract manufacture of private label pregnancy tests for regional pharmacies, drug stores and mass merchants in the United States, Europe, Canada, and Central America. The main products that are marketed and that are commercially available are three HIV Rapid Tests. The three HIV Rapid Tests are Sure CheckT82; HIV and HIV 1/2 Stat-Pak and HIV 1/2 Stat-Pak Dipstick. The products are sold to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, and medical professionals.
Competitor Analysis
This analysis compares Chembio Diagnostics, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
